Cargando…
Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
Background: Evidence suggests that goal anti-Xa levels are achieved in only 33% of critically ill patients receiving standard prophylactic enoxaparin dosing. There has been limited focus on the potential suboptimal anticoagulation effect on medical intensive care unit (MICU) patients receiving thera...
Autores principales: | Abdulla, Aliya, Williams, Caitlin M., Branan, Trisha N., Smith, Susan E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Minnesota Libraries Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686670/ https://www.ncbi.nlm.nih.gov/pubmed/38035321 http://dx.doi.org/10.24926/iip.v14i1.5174 |
Ejemplares similares
-
Low Prevalence of Thrombosis Prophylaxis Dose Adjustments Highlights Implications for Patient Safety
por: Anthony Hawkins, W., et al.
Publicado: (2021) -
Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients
por: Dybdahl, Daniel, et al.
Publicado: (2019) -
Safety and Effectiveness of Reduced Dose Versus Standard Dose
Enoxaparin Venous Thromboembolism Prophylaxis in Underweight Medically Ill
Patients
por: Nemeth, Abigail, et al.
Publicado: (2022) -
Prevention of venous thromboembolism with enoxaparin in bariatirc surgery
por: Woo, Hee Doo, et al.
Publicado: (2013) -
Safety of Enoxaparin as Venous Thromboembolism Prophylaxis After Rhytidectomy
por: Lisiecki, Jeffrey L., et al.
Publicado: (2019)